Investors keep the faith in cancer liquid biopsies

feature-image

Play all audios:

Loading...

NEWS 05 August 2019 Correction 03 June 2020 Correction 03 June 2020 Investors keep the faith in cancer liquid biopsies Despite slow uptake in the clinic, liquid biopsy tests incorporating


methylation and other signatures are showing increasingly compelling data for non-invasive detection of cancer. By Cormac Sheridan0 Cormac Sheridan Dublin, Ireland


View author publications You can also search for this author in PubMed  Google Scholar


Twitter Facebook Email Access through your institution Buy or subscribe Liquid-biopsy platforms, which have long faced considerable scepticism as to their utility in clinical practice, are


attracting a new bout of intense investor interest.

Access options Access through your institution Additional access options: Log in Learn about institutional subscriptions Read our


FAQs Contact customer support


Nature Biotechnology 37, 972-974 (2019)


doi: https://doi.org/10.1038/d41587-019-00022-7


Updates & Corrections Correction 03 June 2020: An earlier version of this article omitted mention in Table 1 of Guardant360’s FDA breakthrough device designation 15 February 2018


Correction 03 June 2020: The Table 1 incorrectly stated that MirXes’ products were at research stage when GastroClear has been available in Singapore since its approval on 9 May 2019 by the


Singapore by the Health Sciences Authority.


Reprints and permissions


Jobs Associate or Senior Editor (Nature Structural & Molecular Biology and Nature Communications) Job Title: Associate or Senior Editor (Nature Structural & Molecular Biology and Nature


Communications)  Location: New York, Shanghai, Beijing, Mad...


New York City, New York (US)


Springer Nature Ltd


Postdoctoral Associate – Nima Sharifi Laboratory The Nima Sharifi Laboratory is seeking to recruit outstanding postdoctoral associates with a primary interest in the fundamental mechanisms


of huma...


Miami, Florida (US)


University of Miami Desai Sethi Urology Institute


Associate or Senior Editor, BMC Medicine Job Title: Associate or Senior Editor, BMC Medicine Location(s): Shanghai – Hybrid working model Application Deadline: June 25th, 2025   About


Spri...


Shanghai – Hybrid working model


Springer Nature Ltd


Faculty Recruitment Announcement: Institute for Future Sciences, University of South China We are currently seeking highly qualified candidates for multiple faculty positions across all


academic ranks within the field of biomedical sciences.


Changsha, Hunan, China


University of South China


Principal Investigator Positions at the Institute for Cancer Research, CIMR, Beijing Beijing (CN)


The Chinese Institutes for Medical Research (CIMR), Beijing